Blonder Tongue Laboratories, Inc.
Blonder Tongue Laboratories, Inc. (BDRL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bdrl · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Blonder Tongue Laboratories, Inc. (BDRL) measures how much investors pay for each dollar of the company's trailing earnings. BDRL's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.06.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%37.7x
MedianQ3 · 75%94.1x
Max
At N/A, BDRL's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Communication Equipment · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Blonder Tongue Laboratories, Inc.You BDRL | $0M | N/A | — | -$0.06 |
 AAP, Inc. AAPJ | $0M | N/A | — | -$0.00 |
 BlueRush Inc. BTVRF | $0M | N/A | — | -$0.07 |
 The Coretec Group Inc. CRTG | $0M | N/A | — | -$0.01 |
 Degama Software Solutions, Inc. DGMA | $0M | N/A | — | -$19604.84 |
 DLT Resolution Inc. DLTI | $78M | N/A | — | -$0.01 |
 Fuse Science, Inc. DROP | $0M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.09 | — | |
2023-12-31 FY2023 | — | $-0.15 | — | |
2022-12-31 FY2022 | — | $-0.28 | — | |
2021-12-31 FY2021 | 85.35x | $0.01 | +1846.9% | |
2020-12-31 FY2020 | 4.38x | $0.30 | — | |
2019-12-31 FY2019 | — | $-0.08 | — | |
2018-12-31 FY2018 | — | $-0.15 | — | |
2017-12-31 FY2017 | — | $-0.05 | — | |
2016-12-31 FY2016 | — | $-0.16 | — | |
2015-12-31 FY2015 | — | $-1.05 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Blonder Tongue Laboratories, Inc. (BDRL) measures how much investors pay for each dollar of the company's trailing earnings. BDRL's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.06.
Frequently asked questions
BDRL pe ratio · 6 questionsBDRL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.01 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via BDRL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Blonder Tongue Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09